老年透析患者导管与动静脉瘘比较:一项先导随机对照试验
该先导随机对照试验在加拿大和澳大利亚12个透析中心纳入67例55岁以上起始血液透析并使用中心静脉导管的患者,随机分为尝试建立动静脉瘘组或继续使用隧道导管组。结果显示25%符合条件患者同意随机,瘘组71%在90天内完成瘘放置;导管策略无伤害信号,多数结局倾向导管组,患者对血管通路有强烈偏好。
要点
- 在老年起始透析患者中开展瘘与导管 definitive RCT 不可行
- 随机至导管策略无伤害信号,多数结局倾向导管组
- 患者对血管通路选择有强烈偏好,应重视共享决策
核心结论
- 当前环境下开展瘘与导管的确定性随机试验不可行
- 随机至导管策略无伤害信号,多数结局倾向导管组
- 患者对血管通路选择有强烈偏好
研究设计与样本
- 在加拿大和澳大利亚12个透析中心进行的先导随机对照试验
- 55岁及以上起始血液透析并使用隧道或非隧道中心静脉导管的患者随机至尝试瘘创建或继续隧道导管
- 主要结局为可行性:符合条件患者同意随机比例及瘘组90天内瘘放置比例
- 共筛查1287例,67例接受随机
主要发现
- 25%符合条件患者同意随机,瘘组71%在90天内接受瘘放置
- 患者拒绝参与最常见原因是偏好继续使用导管透析
- 随机至瘘组名义上有更多通路相关干预、住院和菌血症(多为导管相关),导管组更多依赖溶栓治疗
临床怎么用
- 与患者共享决策时应考虑其对血管通路的强烈偏好
- 对老年起始透析患者,导管策略未显示伤害信号
局限性
- 先导试验样本量小(67例随机),结果需谨慎解读
- 当前环境下确定性试验不可行
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
KEY POINTS: We assessed the feasibility of randomizing hemodialysis patients to an attempt at creating an arteriovenous fistulas with central venous catheters for vascular access. There was no signal of harm associated with randomization to the catheter strategy, and most outcomes favored the catheter group. Patients had strong preferences regarding choice of vascular access, reinforcing the central importance of shared decision making. BACKGROUND: Fistulas are the preferred form of vascular access and historically have been recommended by guidelines because they were associated with improved clinical outcomes and costs. However, there has never been a randomized comparison of catheters with fistulas, and the evidence on which recommendations were based is observational with potential for bias. METHODS: A pilot randomized controlled trial was conducted in 12 hemodialysis centers in Canada and Australia. Patients aged 55 years and older who started hemodialysis using a tunneled or nontunneled central venous catheter for vascular access were randomized to an attempt at fistula creation or continued use of a tunneled central venous hemodialysis catheter. The primary outcome was feasibility, as measured by the proportion of eligible patients who consented to randomization and the proportion of patients randomized to the fistula group who underwent fistula placement within 90 days. Secondary outcomes included invasive access-related procedures, hospitalizations, access-related infections, tissue plasminogen activator usage, and death. RESULTS: A total of 1287 patients were screened, and 67 patients underwent randomization. A total of 25% of eligible patients agreed to randomization, and 71% randomized to the fistula arm underwent fistula placement within 90 days. The most common reason patients declined to participate in the trial was that they preferred to continue to dialyze with their catheter. Patients randomized to fistulas had nominally more access-related interventions, hospitalizations, and bacteremia (most of which were catheter related) while the catheter group experienced greater reliance on thrombolytic therapy. CONCLUSIONS: Findings from this trial suggest that conducting a definitive randomized trial of fistulas versus catheters is not feasible in the current climate. There was no signal of harm associated with randomization to the catheter strategy, and most outcomes favored the catheter group. Patients exhibited strong preferences regarding choice of vascular access. CLINICAL TRIAL REGISTRY NAME AND REGISTRATION NUMBER: ClinicalTrials.gov, NCT02675569 .
引用
- Quinn RR, Oliver MJ, Wald R, et al. Comparing Catheters with Fistulas in Older Patients Starting Hemodialysis: A Pilot Randomized Controlled Trial. J Am Soc Nephrol. 2026. PMID: 42319856. doi:10.1681/ASN.0000001160
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。